Phd in IINNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS

email: maurizio.martelli@uniroma1.it
phone:

Maurizio Martelli MD – “Sapienza” – University of Rome , Italy

Date of birth: July 30, 1956
Place of birth: Rome , Italy
Citizenship: Italian
Marital Status: Married with Roberta Caruso;

Mailing address: Department. of translationl and precision medicine
“Sapienza” – Università di Roma Istituto di Ematologia,
Via Benevento, 6 - 00161 - Roma , Italy

E-mail: (work) martelli@bce.uniroma1.it

Phone (work) + 39 06-857951
Fax: + 39-06-44241984

Education
1987 Postgraduate degree in Oncology (with distinction),“Sapienza” – University of Rome, Italy;
1984 Postgraduate degree in Hematology (with distinction), “Sapienza” – University of Rome, Italy;
1981 Medical degree (with distinction), “Sapienza” – University of Rome, Italy.

Professional records

March 2020 Full Professor of Hematology, - “Sapienza” – University Sapienza Roma
Head of Division Hematology Azienda Policlinico Umberto I Roma

2015 Associate Professor of Hematology, Division of Hematology - “Sapienza” – University of Rome, Italy;
2013 National abilitation of Associate Professor of Hematology;
2006-2015 Assistant Professor/Researcher in Hematology;
2002-2006 Assistant Professor of Hematology, Division of Hematology -“Sapienza” – University of Rome, Italy;
1990-2002 Medical assistant, Division of Hematology - “Sapienza” – University of Rome, Italy;

1986-1989 Recipiant of a grant from A.I.R.C. "Associazione per la Ricerca sul Cancro" - Milan, Italy;
1984-1987 Postgraduate degree, Division of Oncology -“Sapienza” – University of Rome, Italy;
1981-1984 Postgraduate degree, Division of Hematology - “Sapienza” – University of Rome, Italy;
1980-1981 Internship, Division of Hematology - “Sapienza” – University of Rome, Italy.

Internal teaching competences
2009-2017 Lecturer and Member at/of the Postgraduate School of Hematology Ordering Commitee at “Sapienza” – University of Rome with the role of Common Core Mentor
2002-2017 Lecturer at the II Postgraduate School in Clinical Oncology at “Sapienza” – University of Rome - “Blood Malignancies” Course (3rd year);
2007-2008 Lecturer at the I Postgraduate School in Hematology at “Sapienza” – University of Rome
2002-2008 Lecturer at the II Postgraduate School in Clinical and Laboratory Hematology at “Sapienza” – University of Rome – “Physiopathogenetics mechanisms of haematological malignancies” Course (2nd year)

Teaching employments
2010-2017 Lecturer at the II Level University Master “Diagnosis and therapy of Lymphomas” at University of Udine, Italy;

2010-2017 Lecturer at the II Level University Master “Diagnosis and therapy of Lymphomas” at “Sapienza” – University of Rome, Italy;

2010-2017 Co-director of the “Progetto Grandangolo in Ematologia” – updating for Specialists in Hematology;

2007-2008 Lecturer for the Project “Enhance Clinical approach to Lymphoma and Chronic Lymphocytic Leucemia (ECHO)” – A refresher Course for Specialists in Hematology and Oncology;

1998-2009 Lecturer at the Hematology Stages ” at the Hematology and Oncology Institute of the University of Bologna, Italy

Clinical activity
Attending physician at the Institute of Hematology - Sapienza” – University of Rome, Italy from 1990-2008 (in-patient and out-patient care). From 2008 coordinator and responsible of the Lymphoma Unit at the Institute of Hematology – “Sapienza” - University of Rome, Italy.

Communicational Skills and Competences
2002-2017 As a Lecturer he performed more than 130 reports on the diagnosis and therapy of Non-Hodking Lymphomas at Up-dating Courses, National and International Meetings and Symposia of Hematology and Oncology.

Scientific Interests
Clinical trials in Non Hodgkin’s Lymphoma;
GCP experience in more than 20 trials;
2015 - 2017 Chairman of the Italian Lymphoma Foundation (FIL) for the 2015 – 2017 year period;
He is actively involved in Clinical Research on malignant lymphoma and he is currently leading several cooperative multicenter trials in Follicular and Diffuse Large Cell Lymphoma;
2014 - today Member of the New Non Hodgkin Lymphomas SIE Guidelines panel;
2010 - 2017 Member of the Italian Lymphoma Foundation Steering Committee (FIL);
2012 - today Coordinator and International Principal Investigator of the International prospective Study on primitive mediastinal lymphoma (IELSG37);
Member of the Roche Scientific Board for the development and the monitoring of the therapy with monoclonal antibodies in Non Hodgkin Lymhoma;
Member of the International Selected Scientific Committee of the “GOYA” Clinical Trial, a prospective, randomized Study on the therapy with Obinutuzumab in Diffuse Large B Cell Lymphomas;

2011 - 2017 Member of the experts’ panel for the revision and the update of the SIE, SIES, GITMO Guidelines for Follicular Lymphomas therapy;

2013 - 2015 Deputy Chairman of the Italian Lymphoma Foundation (FIL);

2010 - 2015 Member of the Scientific Board of the International Extranodal Lymphoma Study Group (IELSG), under the coordination of Prof. Franco Cavalli (Bellinzona);

2008 - 2013 Coordinator of the Italian Lymphoma Foundation (FIL) Aggressive Non Hodgkin Lymphomas Committee;

2009 - 2010 Member of the experts’ panel at the Consensus Conference on the clinical use of Zevalin therapy in Non Hodgkin Lymphomas;

2000 – 2010 Member of the Scientific Committee of the Italian Lymphomas Intergroup (IIL);

2009 Co- author of the book “ Primary Extranodal Lymphoma”, chapter “Lung Lymphoma” on the diagnosis and the therapy of Extranodal Primitive Non Hodgkin Lymphomas;

2003 - 2008 Principal Investigator of the International Multicentric Prospective Study on the therapy of marginal MALT type Extranodal Lymphomas (IELSG19);

2004 Prinicipal Investigator of the prospective multicentric clinical-biological study on Primitive Mediastinal Lymphomas (IELSG-26);

2003 - 2004 Member of the experts’ panel for the completion of SIE, SIES, GITMO indolent nodal Lymphomas therapy Guidelines, published on 2005;

1988 - 2000 He took part and worked with the Gruppo Cooperatore Italiano, coordinated by the Hematology and Oncology Institute of Bologna for the completion and the monitoring of Prospective Clinical Trials on Lymphomas therapy;

1982 - today Clinical Researcher on lymphoproliferative malignancies, with a special focus on conventional therapy and high dose therapy followed by autologous stem cell transplantation in Non Hodgkin Lymphomas.

Current and previous grant (last 10 years) support
- Ministero dell’Università e della Ricerca (MIUR)
- Roche Pharma, Italy
- Eli Lilly Pharma

Editorial activity
2015 - today Peer-reviewer for Haematological Oncology (IF 2,475); Blood (IF 13,164), Hematology Reports (IF 2,475) and Leukemia and Lymphoma Journals


Scientific Production
Author and Co-author of:
- 116 papers on international Journals with Peer-review;
- 62 abstracts with Peer-review on National and International Meetings;
- more than 117 abstracts and oral communications at National Meetings.

Scientific Societies
Società Italiana di Ematologia (SIE);
Società Italiana di Ematologia Sperimentale (SIES);
European Hematology Association (EHA).

BIBLIOMETRY 1982-2017:
IF (Cumulative) = 686.712
IF 2005-2014 = 259.864
IF first name = 93.459 (9)
IF first and last name = 102.256 (12)

Native language: Italian
Other languages: English: Good reading, communicational and writing skills;
Technical Skills and Comptences: Good knowledge and use of Microsoft office Package (Word, Power Point, Excel)
Driving Licence: B, boat driving licence


Roma, December 27 2022 Prof. Maurizio Martelli